INTRODUCTION: It is estimated that 10-30% of patients with Crohn's disease (CD) have small bowel (SB) involvement, but the exact frequency and clinical relevance of these findings is unknown. Double-balloon enteroscopy (DBE) enables endoscopic visualization of the SB. In this study we evaluated whether DBE is a feasible technique for detection of CD localized in the SB in CD patients with clinical suspicion of SB lesions and whether these findings have clinical impact. METHODS: Retrospectively we analyzed 52 DBE procedures in 40 CD patients (16 males, mean age 40 years, mean duration of CD 15 years). Included patients had clinical suspicion of small bowel CD activity, including persistent abdominal discomfort (n = 27), iron deficiency anemia (n = 9) and/or hypomagnesemia (n = 4). RESULTS: Active small bowel CD was found in 24 (60%) patients, leading to a change in therapy in 18 patients (75%). After a mean follow-up of 13 months, 15 (83%) had persistent clinical improvement with a significant drop of mean CDAI from 178 to 90, after a mean follow-up of 13 months. CONCLUSIONS: DBE is a useful diagnostic tool for the evaluation of SB lesions in CD patients. The significance of these findings is emphasized by the fact that adjustment of therapy in the majority of these patients leads to significant and sustained clinical improvement.
INTRODUCTION: It is estimated that 10-30% of patients with Crohn's disease (CD) have small bowel (SB) involvement, but the exact frequency and clinical relevance of these findings is unknown. Double-balloon enteroscopy (DBE) enables endoscopic visualization of the SB. In this study we evaluated whether DBE is a feasible technique for detection of CD localized in the SB in CDpatients with clinical suspicion of SB lesions and whether these findings have clinical impact. METHODS: Retrospectively we analyzed 52 DBE procedures in 40 CDpatients (16 males, mean age 40 years, mean duration of CD 15 years). Included patients had clinical suspicion of small bowel CD activity, including persistent abdominal discomfort (n = 27), iron deficiency anemia (n = 9) and/or hypomagnesemia (n = 4). RESULTS: Active small bowel CD was found in 24 (60%) patients, leading to a change in therapy in 18 patients (75%). After a mean follow-up of 13 months, 15 (83%) had persistent clinical improvement with a significant drop of mean CDAI from 178 to 90, after a mean follow-up of 13 months. CONCLUSIONS: DBE is a useful diagnostic tool for the evaluation of SB lesions in CDpatients. The significance of these findings is emphasized by the fact that adjustment of therapy in the majority of these patients leads to significant and sustained clinical improvement.
Authors: André Kheng Ho Chong; Andrew Taylor; Ashley Miller; Oliver Hennessy; William Connell; Paul Desmond Journal: Gastrointest Endosc Date: 2005-02 Impact factor: 9.427
Authors: Julia Seiderer; Karin Herrmann; Helmut Diepolder; Stefan O Schoenberg; Andreas C Wagner; Burkhard Göke; Thomas Ochsenkühn; Claus Schäfer Journal: Scand J Gastroenterol Date: 2007-11 Impact factor: 2.423
Authors: William S Mow; Simon K Lo; Stephan R Targan; Marla C Dubinsky; Leo Treyzon; Maria T Abreu-Martin; Konstantinos A Papadakis; Eric A Vasiliauskas Journal: Clin Gastroenterol Hepatol Date: 2004-01 Impact factor: 11.382